Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1446194 BALA CYNWYD, PA
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,317,762
-$9,239,392 QoQ
Shares Held
13,752
-84.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#298
of 774 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Jun 30, 2026
CallValue
$15,067,476
CallShares
89,400
PutValue
$31,213,608
PutShares
185,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. NBIX ranks #14 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,504,358 $108,103,165
2 UTHR
UNITED THERAPEUTICS Corp
 88,579 $47,994,759
3 LQDA
Liquidia Corp
 471,067 $37,558,171
4 BCRX
Biocryst Pharmaceuticals Inc
 1,195,651 $11,956,510
5 PRGO
PERRIGO Co plc
 1,149,496 $11,943,263
6 HROW
Harrow, Inc.
 190,116 $8,074,226
7 VTRS
Viatris Inc
 295,261 $4,688,744
8 TLRY
Tilray Brands, Inc.
 1,021,777 $4,587,778

All Filings in NBIX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,067,476 89,400
2026-06-30 $2,317,762 13,752
2026-06-30 $31,213,608 185,200
2026-03-31 $4,452,812 33,800
2026-03-31 $11,557,154 87,727
2026-03-31 $19,154,996 145,400
2025-12-31 $3,815,227 26,900
2025-12-31 $13,858,634 97,713
2025-12-31 $31,542,992 222,400
2025-09-30 $654,451 4,662
2025-09-30 $24,187,474 172,300
2025-09-30 $20,369,138 145,100
2025-06-30 $9,942,079 79,100
2025-06-30 $11,565,868 92,019
2025-06-30 $14,492,057 115,300
2025-03-31 $17,850,840 161,400
2025-03-31 $11,557,700 104,500
2025-03-31 $14,963,627 135,295
2024-12-31 $3,235,050 23,700
2024-12-31 $1,500,408 10,992
2024-12-31 $12,462,450 91,300
2024-09-30 $8,358,289 72,542
2024-09-30 $16,395,806 142,300
2024-09-30 $18,250,848 158,400
2024-06-30 $10,903,464 79,200
2024-06-30 $5,423,921 39,398
2024-06-30 $22,674,249 164,700
2024-03-31 $15,143,616 109,800
2024-03-31 $24,811,808 179,900
2024-03-31 $5,237,373 37,974
2023-12-31 $12,477,672 94,700
2023-12-31 $5,334,302 40,485
2023-12-31 $21,700,872 164,700
2023-09-30 $15,136,423 134,546
2023-09-30 $20,902,500 185,800
2023-09-30 $10,440,000 92,800
2023-06-30 $9,043,181 95,898
2023-06-30 $3,074,180 32,600
2023-06-30 $13,560,340 143,800
2023-03-31 $4,909,170 48,500
2023-03-31 $8,603,700 85,000
2023-03-31 $4,181,499 41,311
2022-12-31 $4,252,064 35,600
2022-12-31 $656,920 5,500
2022-12-31 $1,553,555 13,007
2022-09-30 $2,031,584 19,128
2022-09-30 $1,858,675 17,500
2022-09-30 $6,776,198 63,800
2022-06-30 $523,467 5,370
2022-06-30 $1,423,208 14,600